Patent 7462608 was granted and assigned to Gilead Sciences on December, 2008 by the United States Patent and Trademark Office.
Phosphorus-substituted imidazole compounds with anti-HIV properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit reverse transcriptase activity and are useful therapeutically for the inhibition of such enzymes, as well as in assays for the detection of such enzymes.